Compares stomach acid control of three proton pump inhibitors in chronic NSAID users (Medical News Today)

home   >   yahoo news

Data from a clinical trial comparing stomach acid control of three proton pump inhibitors (PPIs), esomeprazole magnesium (NEXIUM®), lansoprazole (Prevacid), and pantoprazole (Protonix), in chronic users of non-steroidal anti-inflammatory drugs (NSAIDs) were presented today at the annual Digestive Disease Week® (DDW®). The analysis included users of traditional NSAIDs and selective COX-2

- link to Compares stomach acid control of three proton pump inhibitors in chronic NSAID users (Medical News Today) -
Last update: 05/26/2005

Recommended Reading

    Vascular benefits of statin exceed all expectations: Patients with baseline LDL less than 100 mg/dL also reaped benefits from Zocor. ('Statins are the ... '). : An article from: Internal Medicine News
    Marcos y Germn: Mascaradas de subcomediantes.(actos polticos de cabecillas revolucionarios frente al Congreso mexicano; Mxico)(TT: Marcos and Germn: w ... o)(Artculo Breve) : An article from: Siempre!
    En un acto
    Panel backs copackaged pravachol plus aspirin. (Three Different Doses to be Available). : An article from: Internal Medicine News
    Two more drugs approved for social anxiety. (Sertraline, Venlafaxine). : An article from: Internal Medicine News
    Prozac and the New Antidepressants: What You Need to Know About Prozac, Zoloft, Paxil, Luvox, Wellbutrin, Effexor, Serzone, and More
    Panel Revisits Safety Data on COX-2 Drug Labels.(Brief Article) : An article from: Family Practice News
    En un acto